Correlation Between DBV Technologies and ADC Therapeutics

Can any of the company-specific risk be diversified away by investing in both DBV Technologies and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DBV Technologies and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DBV Technologies and ADC Therapeutics SA, you can compare the effects of market volatilities on DBV Technologies and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DBV Technologies with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DBV Technologies and ADC Therapeutics.

Diversification Opportunities for DBV Technologies and ADC Therapeutics

0.85

Correlation Coefficient

DBV Technologies  ADC Therapeutics

Very poor diversification

The 3 months correlation between DBV and ADC is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding DBV Technologies and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and DBV Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DBV Technologies are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of DBV Technologies i.e., DBV Technologies and ADC Therapeutics go up and down completely randomly.

Pair Corralation between DBV Technologies and ADC Therapeutics

Given the investment horizon of 90 days DBV Technologies is expected to generate 1.21 times more return on investment than ADC Therapeutics. However, DBV Technologies is 1.21 times more volatile than ADC Therapeutics SA. It trades about 0.13 of its potential returns per unit of risk. ADC Therapeutics SA is currently generating about 0.15 per unit of risk. If you would invest  980.00  in DBV Technologies on August 13, 2025 and sell it today you would earn a total of  378.00  from holding DBV Technologies or generate 38.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

DBV Technologies  vs.  ADC Therapeutics SA

DBV Technologies

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in DBV Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, DBV Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

ADC Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ADC Therapeutics SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, ADC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with DBV Technologies and ADC Therapeutics

The main advantage of trading using opposite DBV Technologies and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DBV Technologies position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.

The idea behind DBV Technologies and ADC Therapeutics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.